Search

Matthew J Peerce

Examiner (ID: 3603, Phone: (571)272-6570 , Office: P/2875 )

Most Active Art Unit
2875
Art Unit(s)
2875
Total Applications
592
Issued Applications
390
Pending Applications
57
Abandoned Applications
144

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8486131 [patent_doc_number] => 20120285538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'DYE COMPOUND, DYE-SENSITIZED SOLAR CELL USING THE SAME AND DYE SOLUTION' [patent_app_type] => utility [patent_app_number] => 13/180681 [patent_app_country] => US [patent_app_date] => 2011-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5426 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13180681 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/180681
DYE COMPOUND, DYE-SENSITIZED SOLAR CELL USING THE SAME AND DYE SOLUTION Jul 11, 2011 Abandoned
Array ( [id] => 7712333 [patent_doc_number] => 20120004415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Chiral Synthesis of Pyrrolidine Core Compounds en route to Neuronal Nitric Oxide Synthase Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/174982 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7809 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13174982 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/174982
Chiral synthesis of pyrrolidine core compounds en route to neuronal nitric oxide synthase inhibitors Jun 30, 2011 Issued
Array ( [id] => 7733931 [patent_doc_number] => 20120016130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'PROCESS FOR PREPARING A BIPHENYL-2-YLCARBAMIC ACID' [patent_app_type] => utility [patent_app_number] => 13/173274 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7628 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20120016130.pdf [firstpage_image] =>[orig_patent_app_number] => 13173274 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/173274
Process for preparing a biphenyl-2-ylcarbamic acid Jun 29, 2011 Issued
Array ( [id] => 9413694 [patent_doc_number] => 08697731 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Derivatives of 2-pyridin-2-yl-pyrazol-3(2H)-one, preparation and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 13/172321 [patent_app_country] => US [patent_app_date] => 2011-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17757 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13172321 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/172321
Derivatives of 2-pyridin-2-yl-pyrazol-3(2H)-one, preparation and therapeutic use thereof Jun 28, 2011 Issued
Array ( [id] => 8904844 [patent_doc_number] => 20130172347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'C5AR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/806339 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 24689 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806339 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/806339
C5AR antagonists Jun 23, 2011 Issued
Array ( [id] => 8063633 [patent_doc_number] => 20110245226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/155460 [patent_app_country] => US [patent_app_date] => 2011-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 92882 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245226.pdf [firstpage_image] =>[orig_patent_app_number] => 13155460 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/155460
PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Jun 7, 2011 Abandoned
Array ( [id] => 9958061 [patent_doc_number] => 09006268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'Prolylcarboxypeptidase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/702656 [patent_app_country] => US [patent_app_date] => 2011-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23869 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702656 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/702656
Prolylcarboxypeptidase inhibitors Jun 5, 2011 Issued
Array ( [id] => 6017229 [patent_doc_number] => 20110224440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'PROCESSES FOR THE PREPARATION OF 4-AMINO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/117196 [patent_app_country] => US [patent_app_date] => 2011-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12394 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224440.pdf [firstpage_image] =>[orig_patent_app_number] => 13117196 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/117196
Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds May 26, 2011 Issued
Array ( [id] => 7568064 [patent_doc_number] => 20110288127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE' [patent_app_type] => utility [patent_app_number] => 13/117066 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 11774 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288127.pdf [firstpage_image] =>[orig_patent_app_number] => 13117066 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/117066
Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione May 25, 2011 Issued
Array ( [id] => 8302189 [patent_doc_number] => 20120184748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'RECYCLABLE CATALYSTS FOR ESTERIFICATION OR ACYLATION OF ALCOHOLS' [patent_app_type] => utility [patent_app_number] => 13/115245 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3192 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13115245 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/115245
RECYCLABLE CATALYSTS FOR ESTERIFICATION OR ACYLATION OF ALCOHOLS May 24, 2011 Abandoned
Array ( [id] => 10649319 [patent_doc_number] => 09365553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-14 [patent_title] => 'Heterocyclic compound and H1 receptor antagonist' [patent_app_type] => utility [patent_app_number] => 13/699892 [patent_app_country] => US [patent_app_date] => 2011-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 49820 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699892 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/699892
Heterocyclic compound and H1 receptor antagonist May 22, 2011 Issued
Array ( [id] => 8846330 [patent_doc_number] => 08455512 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Therapeutic pyrazolyl thienopyridines' [patent_app_type] => utility [patent_app_number] => 13/112520 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25950 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112520 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/112520
Therapeutic pyrazolyl thienopyridines May 19, 2011 Issued
Array ( [id] => 7491110 [patent_doc_number] => 20110237802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'LENALIDOMIDE SOLVATES AND PROCESSES' [patent_app_type] => utility [patent_app_number] => 13/109232 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7201 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237802.pdf [firstpage_image] =>[orig_patent_app_number] => 13109232 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/109232
LENALIDOMIDE SOLVATES AND PROCESSES May 16, 2011 Abandoned
Array ( [id] => 8538408 [patent_doc_number] => 08314129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Optical isomers of an iloperidone metabolite' [patent_app_type] => utility [patent_app_number] => 13/096015 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1739 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13096015 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/096015
Optical isomers of an iloperidone metabolite Apr 27, 2011 Issued
Array ( [id] => 7509793 [patent_doc_number] => 20110256064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins' [patent_app_type] => utility [patent_app_number] => 13/087846 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21246 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256064.pdf [firstpage_image] =>[orig_patent_app_number] => 13087846 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/087846
Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins Apr 14, 2011 Abandoned
Array ( [id] => 7561839 [patent_doc_number] => 20110275672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'METHODS FOR TREATING CANCERS USING POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE' [patent_app_type] => utility [patent_app_number] => 13/073897 [patent_app_country] => US [patent_app_date] => 2011-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24826 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275672.pdf [firstpage_image] =>[orig_patent_app_number] => 13073897 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/073897
METHODS FOR TREATING CANCERS USING POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE Mar 27, 2011 Abandoned
Array ( [id] => 7561806 [patent_doc_number] => 20110275639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'C5aR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/072616 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 24723 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275639.pdf [firstpage_image] =>[orig_patent_app_number] => 13072616 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/072616
C5aR ANTAGONISTS Mar 24, 2011 Abandoned
Array ( [id] => 7696095 [patent_doc_number] => 20110230495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => '1-(2-PHENOXYMETHYLHETEROARYL)PIPERIDINE AND PIPERAZINE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/052273 [patent_app_country] => US [patent_app_date] => 2011-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32153 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230495.pdf [firstpage_image] =>[orig_patent_app_number] => 13052273 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/052273
1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds Mar 20, 2011 Issued
Array ( [id] => 8417857 [patent_doc_number] => 20120245357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'ALR2 INHIBITORS AND THEIR SYNTHESIS FROM A NATURAL SOURCE' [patent_app_type] => utility [patent_app_number] => 13/376661 [patent_app_country] => US [patent_app_date] => 2011-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13809 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376661 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/376661
ALR2 INHIBITORS AND THEIR SYNTHESIS FROM A NATURAL SOURCE Mar 20, 2011 Abandoned
Array ( [id] => 7712180 [patent_doc_number] => 20120004315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'Selective Estrogen Receptor Modulator' [patent_app_type] => utility [patent_app_number] => 13/048391 [patent_app_country] => US [patent_app_date] => 2011-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 189820 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13048391 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/048391
Selective estrogen receptor modulator Mar 14, 2011 Issued
Menu